Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
about
Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repairIntegrins as Therapeutic Targets: Successes and Cancers.Beyond adhesion: emerging roles for integrins in control of the tumor microenvironment.Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease.Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma.Differential Expression and Clinical Significance of Transforming Growth Factor-Beta Isoforms in GBM Tumors.How Nanotechnology and Biomedical Engineering Are Supporting the Identification of Predictive Biomarkers in Neuro-Oncology.Re-thinking the preclinical development of GBM therapeutics.The Evolving Role of the Oncologic Neurosurgeon: Looking Beyond Extent of Resection in the Modern Era
P2860
Q33709432-74BE878B-9DC2-4384-87B5-2A3A04EDC4C0Q41670949-52EABEB9-29BA-4D7A-A660-17C4AB4CCC75Q42353677-A2CCCE1F-151F-4967-AC18-14378C5AEA5AQ44411444-33A24A67-F437-4368-9A0B-079A67E3672BQ47243282-82741D96-81CD-4A09-BD13-BFB7F65F2341Q47337262-03109788-E29E-4316-8638-A9613AC66A83Q52593655-3F6CFF73-851F-44E4-AEA3-C2260B7343A1Q52679143-2C642B11-E425-41E1-A593-099EBEA8E899Q54969651-87E77192-C751-4D97-ACB2-A3FB8928A613Q57492114-7EAE2A21-A5B6-43E9-BE0E-52102CCBC140
P2860
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
@en
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome.
@nl
type
label
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
@en
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome.
@nl
prefLabel
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
@en
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome.
@nl
P2093
P2860
P50
P356
P1433
P1476
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
@en
P2093
Christine Hicking
Elisabeth Rushing
Henning Leske
Holger Moch
James Perry
Josef Straub
Martin Picard
Michael Weller
Patrick Roth
Roger Stupp
P2860
P304
15018-15032
P356
10.18632/ONCOTARGET.7588
P407
P577
2016-02-22T00:00:00Z